#KMX-SEC-Update-(06-NOV-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #KMX : $31.65 Sector: Consumer Cyclical | YTD: 🔽 -61.04 % The...
November 2025
#IEV-SEC-Update-(06-NOV-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #IEV : $65.61 Sector: Others | YTD: 🔼+ 26.44 % The SEC...
#IP-SEC-Update-(06-NOV-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #IP : $36.35 Sector: Consumer Cyclical | YTD: 🔽 -31.65 % The...
#WSO-SEC-Update-(06-NOV-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #WSO : $353.32 Sector: Industrials | YTD: 🔽 -24.63 % The SEC...
#DAY-SEC-Update-(06-NOV-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #DAY : $68.59 Sector: Technology | YTD: 🔽 -3.94 % The SEC...
#TEAF-SEC-Update-(06-NOV-2025)-ThinkSabio-Stocks Simplified)
SEC Filing Update: #TEAF : $12.39 Sector: Financial Services | YTD: 🔼+ 2.65 % The...
Cue Biopharma, Inc. (CUE) Stock price, Description, News & Info
#Thinksabio latest news Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy...
Astria Therapeutics, Inc. (ATXS) Stock price, Description, News & Info
#Thinksabio latest news Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in...
BioCryst Pharmaceuticals, Inc. (BCRX) Stock price, Description, News & Info
#Thinksabio latest news BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric...
Nasus Pharma Ltd. (NSRX) Stock price, Description, News & Info
#Thinksabio latest news Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2...